• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgE在哮喘气道上皮中的直接和间接作用

The Direct and Indirect Role of IgE on Airway Epithelium in Asthma.

作者信息

Domingo Christian, Busse William W, Hanania Nicola A, Ertugrul Muyesser, Millette Lauren A, Maio-Twofoot Tina, Jaumont Xavier, Palomares Oscar

机构信息

Department of Pulmonary Medicine, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.

Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

出版信息

Allergy. 2025 Apr;80(4):919-931. doi: 10.1111/all.16459. Epub 2025 Feb 18.

DOI:10.1111/all.16459
PMID:39963805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11969325/
Abstract

Asthma is a chronic airway inflammatory disorder, affecting over 350 million people worldwide, with allergic asthma being the most common form of the disease. Allergic asthma is characterized by a type 2 (T2) inflammatory response triggered by numerous allergens beginning in the airway epithelium, which acts as a physical barrier to allergens as well as other external irritants including infectious agents, and atmospheric pollutants. T2 inflammation is propagated by several key cell types including T helper 2 (Th2) cells, eosinophils, mast cells, and B cells. Immunoglobulin E (IgE), produced by B cells, is a key molecule in allergic airway disease and plays an important role in T2 inflammation, as well as being central to remodeling processes within the airway epithelium. Blocking IgE with omalizumab has been shown to be efficacious in treating allergic asthma however, the role of IgE on airway epithelial cells is less communicated. Developing a deeper explanation of the complex network of interactions between IgE and the airway epithelium will facilitate an improved understanding of asthma pathophysiology. This review discusses the indirect and direct roles of IgE on airway epithelial cells, with a focus on allergic asthma disease.

摘要

哮喘是一种慢性气道炎症性疾病,全球有超过3.5亿人受其影响,其中过敏性哮喘是该疾病最常见的形式。过敏性哮喘的特征是由多种过敏原引发的2型(T2)炎症反应,这种反应始于气道上皮,气道上皮对过敏原以及包括感染因子和大气污染物在内的其他外部刺激物起到物理屏障的作用。T2炎症由几种关键细胞类型介导,包括辅助性T细胞2(Th2)、嗜酸性粒细胞、肥大细胞和B细胞。B细胞产生的免疫球蛋白E(IgE)是过敏性气道疾病中的关键分子,在T2炎症中起重要作用,并且在气道上皮的重塑过程中也至关重要。已证明使用奥马珠单抗阻断IgE在治疗过敏性哮喘方面有效,然而,IgE在气道上皮细胞上的作用鲜为人知。深入解释IgE与气道上皮之间复杂的相互作用网络将有助于更好地理解哮喘的病理生理学。本综述讨论了IgE在气道上皮细胞上的间接和直接作用,重点是过敏性哮喘疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/686dccadd34b/ALL-80-919-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/e56a9b10f889/ALL-80-919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/3911deefdb48/ALL-80-919-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/86110fc56b88/ALL-80-919-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/0e3f4f7df588/ALL-80-919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/686dccadd34b/ALL-80-919-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/e56a9b10f889/ALL-80-919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/3911deefdb48/ALL-80-919-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/86110fc56b88/ALL-80-919-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/0e3f4f7df588/ALL-80-919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/360c/11969325/686dccadd34b/ALL-80-919-g003.jpg

相似文献

1
The Direct and Indirect Role of IgE on Airway Epithelium in Asthma.IgE在哮喘气道上皮中的直接和间接作用
Allergy. 2025 Apr;80(4):919-931. doi: 10.1111/all.16459. Epub 2025 Feb 18.
2
Aeroallergen sensitization in asthma: genetics, environment, and pathophysiology.哮喘中的气传过敏原致敏:遗传学、环境和病理生理学。
Allergy Asthma Proc. 2010 Mar-Apr;31(2):89-95. doi: 10.2500/aap.2010.31.3328.
3
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.抗免疫球蛋白E抗体奥马珠单抗治疗对过敏性哮喘气道炎症的影响。
Am J Respir Crit Care Med. 2004 Sep 15;170(6):583-93. doi: 10.1164/rccm.200312-1651OC. Epub 2004 Jun 1.
4
Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives.重度过敏性哮喘中的抗IgE治疗、气道炎症与重塑:当前认知与未来展望
Eur Respir Rev. 2015 Dec;24(138):594-601. doi: 10.1183/16000617.00001715.
5
Serum IgE Induced Airway Smooth Muscle Cell Remodeling Is Independent of Allergens and Is Prevented by Omalizumab.血清IgE诱导的气道平滑肌细胞重塑与过敏原无关,且可被奥马珠单抗预防。
PLoS One. 2015 Sep 2;10(9):e0136549. doi: 10.1371/journal.pone.0136549. eCollection 2015.
6
Regulatory and IgE B Cells in Allergic Asthma.过敏性哮喘中的调节性和 IgE B 细胞。
Methods Mol Biol. 2021;2270:375-418. doi: 10.1007/978-1-0716-1237-8_21.
7
A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.重组人源化抗IgE单克隆抗体(奥马珠单抗)治疗中重度过敏性哮喘
Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):225-31. doi: 10.2174/187221307782418900.
8
Airway epithelial STAT3 is required for allergic inflammation in a murine model of asthma.在小鼠哮喘模型中,气道上皮中的信号转导和转录激活因子3(STAT3)是过敏性炎症所必需的。
J Immunol. 2007 May 15;178(10):6191-9. doi: 10.4049/jimmunol.178.10.6191.
9
CD23-dependent transcytosis of IgE and immune complex across the polarized human respiratory epithelial cells.CD23 依赖性 IgE 和免疫复合物穿过极化的人呼吸道上皮细胞的转胞吞作用。
J Immunol. 2011 Mar 15;186(6):3484-96. doi: 10.4049/jimmunol.1002146. Epub 2011 Feb 9.
10
Airway epithelial barrier function regulates the pathogenesis of allergic asthma.气道上皮屏障功能调节过敏性哮喘的发病机制。
Clin Exp Allergy. 2014;44(5):620-30. doi: 10.1111/cea.12296.

引用本文的文献

1
Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed.构建了基于PD-L1相关特征的肺腺癌风险评分模型,该模型揭示了预后预测能力以及与肿瘤免疫微环境基因的相关性。
Front Immunol. 2025 Jun 11;16:1601982. doi: 10.3389/fimmu.2025.1601982. eCollection 2025.

本文引用的文献

1
IL-4Rα signaling promotes barrier-altering oncostatin M and IL-6 production in aspirin-exacerbated respiratory disease.白细胞介素-4受体α信号通路促进阿司匹林加重性呼吸疾病中改变屏障的制瘤素M和白细胞介素-6的产生。
J Allergy Clin Immunol. 2024 Aug;154(2):458-467.e3. doi: 10.1016/j.jaci.2024.04.020. Epub 2024 May 3.
2
Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study.奥马珠单抗治疗重度哮喘:对口服皮质类固醇暴露和重塑的影响。一项随机开放标签平行研究。
Drugs. 2023 Aug;83(12):1111-1123. doi: 10.1007/s40265-023-01905-5. Epub 2023 Jul 12.
3
2023 GINA report for asthma.
2023年哮喘全球倡议报告。
Lancet Respir Med. 2023 Jul;11(7):589. doi: 10.1016/S2213-2600(23)00230-8. Epub 2023 Jun 8.
4
On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors.论免疫球蛋白E的复杂性:结构灵活性和糖基化在其与受体结合中的作用
Front Allergy. 2023 Mar 28;4:1117611. doi: 10.3389/falgy.2023.1117611. eCollection 2023.
5
Oncostatin M Contributes to Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps.抑瘤素 M 促进慢性鼻-鼻窦炎伴鼻息肉患者气道上皮细胞功能障碍。
Int J Mol Sci. 2023 Mar 23;24(7):6094. doi: 10.3390/ijms24076094.
6
The Role and Clinical Relevance of Osteopontin in Allergic Airway Diseases.骨桥蛋白在变应性气道疾病中的作用及临床意义
J Clin Med. 2023 Mar 22;12(6):2433. doi: 10.3390/jcm12062433.
7
From the Allergic Cascade to the Epithelium-Driven Disease: The Long Road of Bronchial Asthma.从过敏级联到上皮细胞驱动的疾病:支气管哮喘的漫长道路。
Int J Mol Sci. 2023 Feb 1;24(3):2716. doi: 10.3390/ijms24032716.
8
Prevalence, T2 Biomarkers, and Cost of Severe Asthma in the Era of Biologics: The BRAVO-1 Study.生物制剂时代重度哮喘的患病率、T2 生物标志物和成本:BRAVO-1 研究。
J Investig Allergol Clin Immunol. 2024 Apr 12;34(2):97-105. doi: 10.18176/jiaci.0871. Epub 2022 Nov 24.
9
Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3 Treg generation.利吉珠单抗比奥马珠单抗更有效地抑制IgE与浆细胞样树突状细胞的结合,并恢复IFN-α的产生和FOXP3调节性T细胞的生成。
Allergy. 2023 Apr;78(4):1060-1072. doi: 10.1111/all.15567. Epub 2022 Nov 12.
10
Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity?调节性 T 细胞与免疫球蛋白 E:自身免疫的新治疗靶点?
Allergy. 2022 Nov;77(11):3293-3308. doi: 10.1111/all.15449. Epub 2022 Jul 27.